Choosing the correct modality for the treatment of dysphagia in the patient with esophageal cancer
- PMID: 17004509
Choosing the correct modality for the treatment of dysphagia in the patient with esophageal cancer
Comment on
-
Palliation of malignant dysphagia in esophageal cancer: a literature-based review.J Support Oncol. 2006 Sep;4(8):365-73, 379. J Support Oncol. 2006. PMID: 17004508 Review.
Similar articles
-
An update in the palliative management of malignant dysphagia.Eur J Surg Oncol. 2001 Apr;27(3):332-3. doi: 10.1053/ejso.2000.1072. Eur J Surg Oncol. 2001. PMID: 11373117 No abstract available.
-
Dysphagia: we can relieve this symptom.J Support Oncol. 2006 Sep;4(8):378-9. J Support Oncol. 2006. PMID: 17004510 No abstract available.
-
Palliation of malignant dysphagia in esophageal cancer: a literature-based review.J Support Oncol. 2006 Sep;4(8):365-73, 379. J Support Oncol. 2006. PMID: 17004508 Review.
-
Palliative therapy.J Surg Oncol. 2005 Dec 1;92(3):246-56. doi: 10.1002/jso.20366. J Surg Oncol. 2005. PMID: 16299791 Review.
-
Expandable stents for malignant esophageal disease.Gastrointest Endosc Clin N Am. 2011 Jul;21(3):377-88, vii. doi: 10.1016/j.giec.2011.04.006. Epub 2011 May 10. Gastrointest Endosc Clin N Am. 2011. PMID: 21684460 Review.
Cited by
-
Proton radiotherapy dose perturbations caused by esophageal stents of varying material composition are negligible in an experimental model.Endosc Int Open. 2015 Feb;3(1):E46-50. doi: 10.1055/s-0034-1390709. Epub 2014 Oct 24. Endosc Int Open. 2015. PMID: 26134771 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical